[Elsevier] Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study

SvR Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-07 22:05
Reward10points


Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    1490


Daily Top Contributors

Return to the list